Presentation THT 2022 Changes in Voice Patterns for Monitoring Volume Status (Cardio) Presenter: Chaim S. Lotan February 01, 2022 REGISTER for free or LOG IN to view this content Heart Failure THT 2022 Heart Failure Up Next Presentation THT 2022 Results From First-In-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease Presenter: Barry Greenberg February 01, 2022 More slides + Presentation THT 2022 PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts! Presenter: Roham Zamanian February 01, 2022 Presentation THT 2022 WhiteSwell Presenter: Sitaramesh Emani February 01, 2022 We Recommend Disclosures Nothing to disclose Video Player is loading.Play VideoPlaySkip BackwardSkip ForwardMuteCurrent Time 0:00/Duration 0:00Loaded: 0%0:00Stream Type LIVESeek to live, currently behind liveLIVERemaining Time -0:00 1xPlayback Rate2x1.75x1.5x1.25x1x, selected0.75x0.5xChaptersChaptersDescriptionsdescriptions off, selectedCaptionscaptions settings, opens captions settings dialogcaptions off, selectedAudio TrackPicture-in-PictureFullscreenThis is a modal window.Beginning of dialog window. Escape will cancel and close the window.TextColorWhiteBlackRedGreenBlueYellowMagentaCyanOpacityOpaqueSemi-TransparentText BackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanOpacityOpaqueSemi-TransparentTransparentCaption Area BackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanOpacityTransparentSemi-TransparentOpaqueFont Size50%75%100%125%150%175%200%300%400%Text Edge StyleNoneRaisedDepressedUniformDrop shadowFont FamilyProportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall CapsResetDoneClose Modal DialogEnd of dialog window.Close Modal DialogThis is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Presentation THT 2022 Results From First-In-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease Presenter: Barry Greenberg February 01, 2022
Presentation THT 2022 PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts! Presenter: Roham Zamanian February 01, 2022